Back

Clopidogrel versus aspirin as long-term monotherapy after PCI with drug-eluting stents: a systematic review and meta-analysis

20 February 2026 (09:45 - 10:30)
Organised by: Logo
Congress Presentation Part of: Poster session (2) - Pharmacology and pharmacotherapy Antiplatelet Drugs EAPCI Premium Access EAPCI Summit 2026 European Association of Percutaneous Cardiovascular Interventions (EAPCI)

About the speaker

Photo
Doctor Ahmed Emara

Faculty of Medicine - Menofia University, Menoufia (Egypt)

4 More presentations in this session

Presentation thumbnail
Professor M. Valgimigli (Lugano, CH)
Abstract Slides
Presentation thumbnail
Doctor A. Laino (Naples, IT)
Abstract Slides
Presentation thumbnail
Mr J. Rogozarski (Vienna, AT)
Abstract Slides
Presentation thumbnail

Access the full session

Session thumbnail
Poster session (2) - Pharmacology and pharmacotherapy

The Event

Event poster

EAPCI Summit 2026

20 February 2026 09:45 CET
You may be interested in
thumbnail
Congress Presentation
Aspirin versus clopidogrel beyond 1 month after acute coronary syndrome with high bleeding risk or ST-elevation myocardial infarction: pre-specified subanalyses of the STOPDAPT-3
1 September 2025
thumbnail
Congress Presentation
Choice of monotherapy following short duration of dual-antiplatelet therapy after percutaneous coronary intervention: a meta-analysis of randomized clinical trials
31 August 2025
thumbnail
Congress Presentation
Is there an inter-manufacturer difference in generic clopidogrel response?
26 August 2022
thumbnail
Congress Presentation
Real world outcomes for clopidogrel versus ticagrelor treated patients with acute coronary syndrome: a systematic literature review and meta-analysis
2 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources